VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TELATELA Bio, Inc.
$0.74$33M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTELAQuarterly Cash Flow

TELA Bio, Inc. (TELA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

TELA Bio, Inc. (TELA) quarterly cash flow statement — complete operating, investing & financing history

TELA Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Cash from Operations-11.17M-4.87M-5.72M-7.91M-9.72M-7.53M-8.98M-10.7M-14.38M-11.05M-6.97M-11.26M
Operating CF Margin %-58.61%-23.34%-27.64%-39.14%-52.51%-42.67%-47.39%-66.48%-86.63%-65.01%-46.29%-77.71%
Operating CF Growth %-14.86%35.33%36.34%26.1%32.39%31.85%-28.92%5.03%-24.28%-0.62%8.9%3.61%
Net Income-12.27M-9.04M-8.6M-9.92M-11.26M-9.21M-10.37M-12.6M-5.66M-12.89M-10.96M-10.79M
Depreciation & Amortization0225K248K270K267K266K263K249K234K161K218K214K
Stock-Based Compensation0812K0985K1.04M1.09M1.08M1.09M1.1M1.24M1.37M1.29M
Deferred Taxes0145K033K52K0000000
Other Non-Cash Items2.31M1.84M2.07M363K755K1.25M824K-447K-5.38M-978K242K-2.75M
Working Capital Changes-1.21M1.15M564K367K-579K-926K-779K1.01M-4.68M1.42M2.16M764K
Change in Receivables593K932K-107K-533K-402K983K-2.01M497K-234K-1.6M-237K-1.2M
Change in Inventory-2.16M-275K-838K1.96M-1.35M-616K-811K-115K-1.43M785K-567K924K
Change in Payables1.59M-63K652K-2.3M1.85M-154K0000884K0
Cash from Investing190K192K312K204K138K-190K-122K67K4.7M-193K-134K-157K
Capital Expenditures-119K-91K-211K-114K-32K-264K-122K-299K-304K-205K-134K-157K
CapEx % of Revenue0.62%0.44%1.02%0.56%0.17%1.5%0.64%1.86%1.83%1.21%0.89%1.08%
Acquisitions309K283K523K000000000
Investments------------
Other Investing000318K170K74K0366K5M12K00
Cash from Financing-298K25.84M24K-3K-116K42.91M98K-5K56K22K71K46.41M
Debt Issued (Net)014.03M0000000000
Equity Issued (Net)28K11.82M45K-3K61K42.92M-19K-11K-328K-4K-13K-1K
Dividends Paid000000000000
Share Repurchases000-3K0-11K-19K-11K-328K-4K0-1K
Other Financing-326K-4K-21K0-177K-11K117K6K384K26K84K46.41M
Net Change in Cash-11.3M21.13M-5.26M-7.86M-9.84M35.37M-9.2M-10.65M-9.59M-11.21M-7.06M35.14M
Free Cash Flow-11.29M-4.96M-5.93M-8.02M-9.76M-7.79M-9.11M-11M-14.69M-11.26M-7.1M-11.42M
FCF Margin %-59.23%-23.77%-28.66%-39.7%-52.68%-44.17%-48.03%-68.34%-88.47%-66.22%-47.18%-78.8%
FCF Growth %-15.7%36.36%34.87%27.07%33.57%30.75%-28.2%3.72%-25.66%6.43%10.54%3.91%
FCF per Share-0.20-0.10-0.13-0.18-0.22-0.19-0.37-0.45-0.60-0.46-0.29-0.49
FCF Conversion (FCF/Net Income)0.91x0.54x0.66x0.80x0.86x0.82x0.87x0.85x2.54x0.86x0.64x1.04x
Interest Paid00001.37M519K1.19M1.18M1.18M1.19M1.18M1.15M
Taxes Paid000000000000